The American scientist James Lyons-Weilier has published on his IPAK (Institute for Pure and Applied Knowledge) website a very interesting study conducted by a university professor of economics from Michigan State University, Mark Skidmore, which analyzed the positive incidence of the use of Hydroxychloriquine against COVID-19 that may have prevented over 520,000 deaths in Western countries where was banned, and at least 420,000 in the US only.
The academic professor discovered that African countries, where it was already routinely used against malaria, noted an enormous benefit compared to those of the European Union and the USA where it was instead excluded from therapies authorized by health bodies after many disputes.
In Italy a legal challenge reached the Council of State, after the Regional Administrative Court of Lazio (TAR in Italian acronymous) had accepted the appeal of an association that opposed the government health protocol of “paracetamol and watchful waiting” highlighting the usefulness of HCQ and Vitamin D.